U.S. regulators strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to a rare but serious risk of blood clots. The Food and Drug Administration (FDA) said on May 5 that the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. Under the new FDA instructions, J&J's vaccine could still be given to people who had a severe allergic reaction to one of the other vaccines and couldn't receive an additional dose. Still, regulators added warnings about the blood clots and a rare neurological reaction called Guillain-Barré syndrome. Less than 17 million Americans have received the J&J shot so far.
For more:
https://news.cgtn.com/news/2022-05-06/FDA-restricts-Johnson-Johnson-COVID-vaccine-due-to-clot-risk-19ONiv3mLUk/index.html
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
